Institutional Ownership Elevation Oncology, Inc. (ELEV)
This table provides information about the institutional ownership of Elevation Oncology, Inc. (ELEV). We have compiled data on the 71 institutions that hold shares in the stock, with a total of 39.1 Million shares, which have been reported (via 13F filing form) to have a value of $25 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Feb 14, 2025 Q4 2024 |
5,993,579
shares
|
$3.84 Million
0.21% of portfolio
|
Q3 2024
Added 102.58%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
4,760,000
shares
|
$3.05 Million
0.21% of portfolio
|
Q3 2024
Added 55.56%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
3,527,482
shares
|
$2.26 Million
0.01% of portfolio
|
Q3 2024
Reduced 1.97%
|
|
|
Bvf Inc
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,966,836
shares
|
$1.9 Million
0.06% of portfolio
|
Q3 2024
Added 28.31%
|
|
|
Aisling Capital Management LP
New York, NY |
Feb 12, 2025 Q4 2024 |
2,834,910
shares
|
$1.81 Million
0.6% of portfolio
|
Q2 2021
New holding
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
2,610,045
shares
|
$1.67 Million
0.0% of portfolio
|
Q4 2024
Reduced 15.03%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,490,249
shares
|
$1.59 Million
0.0% of portfolio
|
Q2 2024
Added 1348.65%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,651,723
shares
|
$1.06 Million
0.0% of portfolio
|
Q4 2024
Reduced 58.59%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
1,603,309
shares
|
$1.03 Million
0.0% of portfolio
|
Q4 2024
Reduced 10.23%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,157,572
shares
|
$740,846
0.0% of portfolio
|
Q4 2024
Added 4.28%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,071,883
shares
|
$686,005
0.0% of portfolio
|
Q4 2024
Added 5.29%
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
1,018,562
shares
|
$651,879
0.12% of portfolio
|
Q4 2024
Reduced 5.67%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
941,275
shares
|
$602,416
0.01% of portfolio
|
Q1 2024
Reduced 37.25%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
815,916
shares
|
$522,186
0.0% of portfolio
|
Q4 2024
Added 3.88%
|
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
690,050
shares
|
$441,632
0.07% of portfolio
|
Q4 2024
Reduced 0.01%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Feb 14, 2025 Q4 2024 |
444,039
shares
|
$284,184
0.0% of portfolio
|
Q4 2024
Added 0.81%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
432,620
shares
|
$276,876
0.0% of portfolio
|
Q4 2024
Added 15.91%
|
|
|
Allostery Investments LP
Stamford, CT |
Feb 14, 2025 Q4 2024 |
432,206
shares
|
$276,611
0.25% of portfolio
|
Q4 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
420,437
shares
|
$269,079
0.0% of portfolio
|
Q4 2024
Reduced 55.79%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
333,300
shares
|
$213,312
0.0% of portfolio
|
Q4 2024
Reduced 38.65%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
266,243
shares
|
$170,395
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
215,950
shares
|
$138,208
0.0% of portfolio
|
Q4 2024
Reduced 0.02%
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Feb 13, 2025 Q4 2024 |
200,000
shares
|
$128,000
0.09% of portfolio
|
Q4 2024
New holding
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
188,771
shares
|
$120,813
0.0% of portfolio
|
Q4 2024
Added 550.49%
|
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
183,454
shares
|
$117,410
0.0% of portfolio
|
Q4 2024
Reduced 0.02%
|